The Cigna Group

As of June 30, 2026, Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh carries a market capitalization of 380.96B, placing it among publicly traded companies globally. Its enterprise value stands at 510.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh has 6.27B shares outstanding.

As of June 30, 2026, Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh trades at a trailing price-to-earnings ratio of 11.49. The price-to-sales ratio is 0.26, and the price-to-book ratio stands at 1.73.

As of June 30, 2026, Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh trades at an EV/EBITDA multiple of 7.78 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.35 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 9.91 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh trades at an EV/FCF ratio of 9.62, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 510.18B versus a market cap of 380.96B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh maintains a current ratio of 0.85, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 74.29, indicating elevated leverage, while an interest coverage ratio of 8.92 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh posted a return on equity (ROE) of 15.49, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 12.22 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 4.16, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 9.59, useful for judging operating efficiency across full business cycles. The company generates approximately 21.03M in revenue per employee across its workforce of 69,150.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 43.44 indicates how many times Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh recorded 8.56B in income tax expense. That works out to an effective tax rate of 19.17, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 44.65B, leaving 33.16B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 20, 2026, Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh's stock has declined approximately 5.29% over the past 52 weeks. The 50-day moving average sits at 59.63, while the 200-day moving average is 64.96.

Over the twelve months ended June 30, 2026, Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh generated 1.45T in revenue and converted that into 33.16B in net income, yielding earnings per share of 5.72. EBITDA reached 65.55B, while operating income came in at 46.06B.

As of June 30, 2026, Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh holds 37.06B in cash and equivalents against 164.78B in total debt, resulting in a net debt position of 132.22B. Total book value stands at 220.30B, with working capital of -44.30B providing operational flexibility.

Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh produced 53.12B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -6.02B in capital expenditures, free cash flow totaled 47.11B - equivalent to 7.51 per share.

Over the twelve months ended June 30, 2026, Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh posted a gross margin of 8.80, reflecting its pricing power and cost economics. The operating margin of 3.17 and net profit margin of 2.28 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh paid dividends of 1.34 per share. The dividend payout ratio of 21.51 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 12.29, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 3.18, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh shareholders.

Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh's most recent stock split took place on August 10, 2026 with a 1:6 split ratio.

As of June 30, 2026, Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 0.041667 Sh has an Altman Z-Score of 4.77, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.